-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
IDG Capital
- Investments: 1456
- Funds: 140
- Beijing
-
Grid/power transmission
IDG Capital, founded in 1992, is a leading investment institution in the world, focusing on supporting outstanding enterprises in different growth cycles to achieve rapid development through venture capital, private equity and industrial development. IGD Capital has invested in more than 1,400 enterprises including 360, Baidu, Ctrip.com, Afu Essential Oil, Andon Medical, Archermind, Baofeng, Bilibili, Cobos, Bosideng, Birentech, China UMS, Fftai, Heytea, Iqiyi, Ijovo and Three Squirrels. IDG Capital has one of the most complete and experienced professional teams in the industry. The team members have diversified industry backgrounds and global investment perspectives and resources, and their education and working backgrounds cover many industries such as technology, market, finance, law, management consulting and investment banking.
-
ASB Ventures
- Investments: 76
- Funds: 10
- Shenzhen, Guangdong Province
-
Grid/power transmission
ASB Ventures officially entered mainland China and jointly established a RMB private equity investment fund management institution-Shenzhen Huaao Capital Management Co., Ltd. with professional institutions, including China Venture Capital Co., LTD and Shenzhen United Property and Equity Exchange in 2009. In 2015, we adjusted the equity and changed our name to Shenzhen ASB Ventures Management Co., Ltd. The funds under ASB Ventures include ASB New Industry Venture Capital FOF and Huaao Venture Capital Series Funds (No. I-V)---two RMB private equity venture capital funds independently managed by Shenzhen ASB Ventures Management Co., Ltd. and our holding subsidiaries, and ASB China Fund (No. I-IV), an offshore US dollar family venture capital fund independently managed by ABS China Holdings Co., Ltd. We focus on venture capital in the fields of biomedicine and health, TMT and creativity, and hardware technology and clean technology (in the form of FOF combined with direct investment in projects), and private investment fund management. We also provide high quality financial and governance services.
-
Haier Capital
- Investments: 139
- Funds: 19
- Shanghai
-
Grid/power transmission
Haier Capital, founded in 2010, is the investment platform of Haier Financial Holding. Our business mainly involve venture capital, private equity investment, industrial mergers and acquisitions, and government guidance funds. Haier Capital focuses on the medical health field, including medical technology, medical services, medical equipments, and biomedicine. So far, we have managed more than 20 billion investment assets. We invest in smart technology, innovative consumption, andmedical health. The investment enterprises include Ijiami, Ubox, Dayun Motor, Dekun, Huatu Education, and Create LED.
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Grid/power transmission
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
-
Landstone CAPITAL
- Investments: 48
- Funds: 11
- Tianjin
-
Grid/power transmission
Landstore Capital was jointly established by the founding team, Tsinghua University TusStar, and the listed company TQM in September 2015. The investment institutions include government guidance funds, listed companies, large state-owned enterprises, private institutions, etc. We focus on the hard technology equity investment in the primary market, especially on fields including aerospace, smart car industrial chain, new materials, new information technology, semiconductors, and high-end equipment. We have rich industrial resources, strong scientific research resources, win-win business synergy, and successful entrepreneurial experience. We are committed to being a respectable institution, making valuable investment for the society, being an important cornerstone to support national scientific and technological innovation, and becoming the best partner for technological entrepreneurship and industrial innovation.